Market News & Trends
Cardiovascular Disease Market: US to Lead Modest Growth; Electronic Cigarettes Could Be the Next Blockbuster
The global market for Cardiovascular Disease (CVD) - composed of Heart Failure (HF), Myocardial Infarction (MI), and Acute Coronary Syndrome (ACS) - is expected to…
Kytosan USA Looks to Become Market Leader for Domestic Chitosan
Under an exclusive patent licensing agreement from its parent, KYTOSAN USA will produce and market high-quality industrial-grade chitosan, a specialty chemical made from discarded crustacean…
Unilife Announces Clinical Supply Agreement With Novartis
Unilife recently announced an agreement with Novartis to supply clinical products from one of its platforms of injectable drug delivery systems for use with one…
Hovione’s New Inhalation Capsule Filling Machine Fills Market Gap
Hovione recently announced the expansion of its inhalation drug product development services with the introduction of a high-precision MG2 FlexaLAB capsule filling machine. This investment…
Ganymed Pharmaceuticals Closes Significant Financing Round
Ganymed Pharmaceuticals AG, a biopharmaceutical company developing highly selective Ideal Monoclonal Antibodies (IMABs) for the treatment of cancer, recently announced the completion of a EUR…
Avalon Ventures-GlaxoSmithKline Launch Sitari Pharm
Avalon Ventures recently announced the launch of Sitari Pharmaceuticals, the first company formed by Avalon and GlaxoSmithKline (GSK) under a unique collaboration recently established to…
Alnylam Earns $7 Million Milestone Payment from Genzyme
Alnylam Pharmaceuticals, Inc. recently announced it has earned a $7-million milestone from its partner Genzyme, a Sanofi company, for achieving Phase II success with patisiran…
IBM Research & Institute of Bioengineering & Nanotechnology Discover Breakthrough for Breast Cancer Delivery
Recently, scientists from IBM and Singapore's Institute of Bioengineering and Nanotechnology published a breakthrough drug delivery technique, demonstrating the first biodegradable, biocompatible, and non-toxic hydrogel…
Aquavit Pharmaceuticals Adds Advanced Delivery Technology to Portfolio
Aquavit Pharmaceuticals, Inc. has further extended its personalized drug delivery platform by signing a binding preliminary agreement with Huons Co, Ltd., a leading Korean pharmaceuticals…
Egalet, Shionogi Sign $425-Million Plus Deal
Egalet Corporation recently announced it has entered into a definitive collaboration and license agreement with Shionogi Limited for the development and potential commercialization of multiple…
Oramed Pharmaceuticals Receives Patent for the Oral Delivery of Insulin
Oramed Pharmaceuticals Inc. recently announced that the European Patent Office has allowed the company's patent for its invention, titled Methods and Compositions for Oral Administrations…
Rapid Delivery Program Product Portfolio Expands to Biopharmaceutical Injectable Market
BD Medical recently announced the BD Accelerate program now offers a solution for the biopharmaceutical injectable drug market with the BD Neopak Glass Prefillable Syringe…
Pure MHC & Catalent Sign Cancer Development Deal
Pure MHC, LLC and Catalent Pharma Solutions recently announced the signing of a product development agreement. Under the terms of the agreement, Catalent will develop…
Unilife Signs Long-Term Supply Agreement with Hikma
Unilife recently announced the signing of a long-term commercial supply contract with Hikma Pharmaceuticals PLC for the use of Unifill prefilled syringes with a range…
Royal DSM & JLL Create Leading Pharma Services Company in $ 2.6-Billion Transaction
LL Partners and Royal DSM recently announced the creation of a new company, which will be a leading global contract development and manufacturing organization (CDMO)…
3M Licenses Fentanyl Transdermal Patch Technology
3M Drug Delivery Systems recently announced that STADA Arzneimittel AG has become the latest drug company to license 3M’s patented technology directed to a matrix…
Merck Enters Further Global Co-Development & Commercialization Agreement With BeiGene
Merck Serono recently announced that a global licensing, co-development, and commercialization agreement for BeiGene-290 has been signed with BeiGene Co., Ltd., a biotech research and…
Baxter International & Cell Therapeutics Announce Worldwide Strategic Collaboration
Baxter International Inc. and Cell Therapeutics, Inc. recently announced they have entered into an exclusive worldwide licensing agreement to develop and commercialize pacritinib, a novel…
Unilife Announces Supply Agreement With MedImmune
Unilife Corporation recently announced an agreement with MedImmune to customize and supply devices from its platform of wearable injectors for use with molecules in MedImmune’s…
Oncodesign & UCB Enter Strategic R&D Collaboration
Oncodesign recently announced it has entered into a research collaboration and exclusive license option with UCB. The collaboration will leverage the respective expertise of Oncodesign…
